industry-perspectives-sponsored 
Worldwide Clinical Trials
FEBRUARY 26, 2024
Among the various topics discussed, here are a few highlights of the panelists’ conversation: Challenging Traditional Approaches As an industry, Perez points out that we tend to stick to what we are accustomed to in terms of protocol design and traditional clinical operations. And, frankly, none of them are wrong. “And,
Worldwide Clinical Trials
AUGUST 10, 2023
Sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS), the event was the largest psychedelics conference in history, bringing in approximately 12,000 participants and 300+ speakers from around the world.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
WCG Clinical
SEPTEMBER 11, 2023
When it comes to clinical trials, sponsor and provider organizations understand that sites are motivated by the science and the patients, and they recognize sites are under a tremendous strain. That was one of the key takeaways from the 2023 Avoca State of the Industry Survey. This annual survey typically polls sponsors and providers.
Clinical Trial Gurus
AUGUST 21, 2021
A clinical research coordinator compares industry sponsored trials and investigator initiated trials in terms of working on the studies from a CRC perspective.
ACRP blog
MARCH 28, 2024
Food and Drug Administration,¹ as an industry we haven’t made huge strides in adopting this model for interventional studies,” notes Noelle Gaskill, Head of Clinical Research Collaborations at Mirati Therapeutics, Inc. Sponsors have often tended to have preferred technologies that sites are asked to use.
Pharmaceutical Technology
APRIL 20, 2023
Clinical trials were really not optimised from the perspective of the patient, site orthe sponsor; they are increasingly cost ineffective, and they take a lot of time. They are expected to peak even higher in 2022, with GlobalData forecasting the industry to hold approximately 1,425 DCTs by the end of the year. [2]
pharmaphorum
SEPTEMBER 14, 2022
It’s through that sharp lens that the pharma industry also saw an all-time high in consumer interest in clinical research during the pandemic. Leveraging patient perspectives. respondents and a third of EU respondents reported that their trust in clinical research and the pharma industry had increased since the start of the pandemic.
Expert insights. Personalized for you.
144 
Let's personalize your content